
Featured
Beyond Weight Loss: CDC Reports GLP-1 Agonists Driving Unprecedented Decline in National Cardiovascular Event Rates
The CDC reports that the widespread adoption of GLP-1 receptor agonists is driving an unprecedented 12% decline in national cardiovascular event rates...
Read Full Story →